| Heatherwood Rehabilitation & Health Care Center | |
| 398 Bellevue Avenue, Newport, Rhode Island 02840 | |
| (401) 849-6600 | |
| Name | Heatherwood Rehabilitation & Health Care Center |
|---|---|
| Location | 398 Bellevue Avenue, Newport, Rhode Island |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 114 |
| Occupancy Rate | 82.72% |
| Medicare ID (CCN) | 415033 |
| Legal Business Name | Heatherwood Ri Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1427469105 |
| Organization Name | HEATHERWOOD RI LLC |
| Doing Business As | HEATHERWOOD REHABILITATION & HEALTH CARE CENTER |
| Address | 398 Bellevue Ave, Newport, RI 02840 |
| Phone Number | 401-849-6600 |
News Archive
Autologous fat grafting following breast reconstruction does not increase the long-term risk for tumor recurrence, US research shows.
A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.
The drug diABZI which activates the body's innate immune response - was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania
When the U.S. Government's new prescription drug benefit begins next year a category of drugs commonly used to treat anxiety, insomnia and seizures will not be included.
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
› Verified 8 days ago
| NPI Number | 1902887029 |
| Organization Name | HEATHERWOOD NURSING AND REHABILITATION CENTER INC |
| Doing Business As | HEATHERWOOD NURSING AND SUBACUTE CENTER INC |
| Address | 398 Bellevue Ave, Newport, RI 02840 |
| Phone Number | 401-849-6600 |
News Archive
Autologous fat grafting following breast reconstruction does not increase the long-term risk for tumor recurrence, US research shows.
A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.
The drug diABZI which activates the body's innate immune response - was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania
When the U.S. Government's new prescription drug benefit begins next year a category of drugs commonly used to treat anxiety, insomnia and seizures will not be included.
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Autologous fat grafting following breast reconstruction does not increase the long-term risk for tumor recurrence, US research shows.
A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.
The drug diABZI which activates the body's innate immune response - was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania
When the U.S. Government's new prescription drug benefit begins next year a category of drugs commonly used to treat anxiety, insomnia and seizures will not be included.
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.87 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.11 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 36.65 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.26 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.83 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.75 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 9.26 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 24.51 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 86.84 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.35 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.77 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.94 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.83 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 80.97 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.53 | 82.93 |
News Archive
Autologous fat grafting following breast reconstruction does not increase the long-term risk for tumor recurrence, US research shows.
A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.
The drug diABZI which activates the body's innate immune response - was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania
When the U.S. Government's new prescription drug benefit begins next year a category of drugs commonly used to treat anxiety, insomnia and seizures will not be included.
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
› Verified 8 days ago
Heatherwood Rehabilitation & Health Care Center Location: 398 Bellevue Avenue, Newport, Rhode Island 02840 Phone: (401) 849-6600 | |
Village House Nursing & Rehabilitation Center Location: 70 Harrison Avenue, Newport, Rhode Island 02840 Phone: (401) 849-5222 | |